Home › Companies › OUTLOOK THERAPEUTICS INC. › 2024-2025
At OUTLOOK THERAPEUTICS INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held August 12, 2024 and March 11, 2025), 87 asset managers reported how they voted in their SEC Form N-PX filings, covering 599 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held March 11, 2025 — A NON-BINDING ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — OUTLOOK THERAPEUTICS INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: OUTLOOK THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on March 14, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and OUTLOOK THERAPEUTICS INC.’s Form 8-K, filed March 14, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of March 11, 2025: 7 items on OUTLOOK THERAPEUTICS INC.’s Form 8-K, filed March 14, 2025: 3 elected · 4 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore OUTLOOK THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are OUTLOOK THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed March 14, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Julian Gangolli | 10,171,948 | -- | -- | 768,383 | 5,470,688 | 93% | Elected | — |
| Elect Director: Ralph H. "Randy" Thurman | 9,939,530 | -- | -- | 1,000,801 | 5,470,688 | 91% | Elected | — |
| Elect Director: Lawrence A. Kenyon | 10,152,131 | -- | -- | 788,200 | 5,470,688 | 93% | Elected | — |
| 2. The potential issuance in excess of 19.99% of the Company's outstanding common stock upon the conversion of the Note at a conversion price per share that is less than the "minimum price" under Nasdaq Listing Rule 5635, if required pursuant to the | 10,366,884 | 548,242 | 25,205 | -- | 5,470,688 | 95% | Approved | — |
| 3. The amendment of the Company's Restated Certificate of Incorporation to increase the total number of shares of its common stock authorized for issuance from 60,000,000 to 260,000,000 shares | 10,116,359 | 802,107 | 21,865 | -- | 5,470,688 | 93% | Approved | — |
| 4. The selection by the Audit Committee of the Board of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year ending September 30, 2025 | 15,943,368 | 251,344 | 216,306 | -- | 0 | 98% | Approved | — |
| 5. Non-binding advisory vote on the compensation of the Company's named executive officers | 9,972,197 | 908,929 | 59,205 | -- | 5,470,688 | 92% | Approved | — |
Source: OUTLOOK THERAPEUTICS INC., Form 8-K, filed with the SEC on March 14, 2025 — read the filing on EDGAR.
Each item below shows how the 87 asset managers that disclosed a OUTLOOK THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of OUTLOOK THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held March 11, 2025.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To elect the following members of Class III of the Company's board of directors: Julian Gangolli
OUTLOOK THERAPEUTICS INC.’s own tally for this item (“Elect Director: Julian Gangolli”): 10,171,948 for, 768,383 withheld, per its Form 8-K filed March 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Stockholders elected each of the following nominees to serve as Class III directors on the Company's Board of Directors (the "Board") until the Company's 2028 Annual Meeting of Stockholders or until his successor has been duly elected and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 23 asset managers below reported 91,639 for, 6,613 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,308 | 0 | 0 | 0 | For |
| BlackRock | 8,773 | 0 | 0 | 0 | For |
| Pacific Life | 7,242 | 0 | 0 | 0 | For |
| Lincoln Financial | 6,724 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,414 | 0 | 0 | 0 | For |
| Equitable | 2,752 | 0 | 0 | 886 | Mixed |
| Northern Trust | 2,855 | 0 | 0 | 0 | For |
| Global X | 2,501 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 2,234 | Withhold |
| Charles Schwab | 1,888 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 1,771 | Withhold |
| Fidelity | 1,573 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,222 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 1,006 | Withhold |
| SEI | 935 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 607 | Withhold |
| State Street | 576 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 461 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 345 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 0 | 109 | Withhold |
| Advisors' Inner Circle Fund III | 55 | 0 | 0 | 0 | For |
| T. Rowe Price | 13 | 0 | 0 | 0 | For |
| Nationwide | 2 | 0 | 0 | 0 | For |
Meeting held March 11, 2025.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To elect the following members of Class III of the Company's board of directors: Lawrence A. Kenyon
OUTLOOK THERAPEUTICS INC.’s own tally for this item (“Elect Director: Lawrence A. Kenyon”): 10,152,131 for, 788,200 withheld, per its Form 8-K filed March 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Stockholders elected each of the following nominees to serve as Class III directors on the Company's Board of Directors (the "Board") until the Company's 2028 Annual Meeting of Stockholders or until his successor has been duly elected and qualified.”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 23 asset managers below reported 89,089 for, 9,163 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,308 | 0 | 0 | 0 | For |
| BlackRock | 8,773 | 0 | 0 | 0 | For |
| Pacific Life | 7,242 | 0 | 0 | 0 | For |
| Lincoln Financial | 6,724 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,414 | 0 | 0 | 0 | For |
| Equitable | 3,638 | 0 | 0 | 0 | For |
| Northern Trust | 2,855 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 2,501 | Withhold |
| DWS | 0 | 0 | 0 | 2,234 | Withhold |
| Charles Schwab | 1,888 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 1,771 | Withhold |
| Fidelity | 1,573 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,222 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 1,006 | Withhold |
| SEI | 0 | 0 | 0 | 935 | Withhold |
| Calvert | 0 | 0 | 0 | 607 | Withhold |
| State Street | 576 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 461 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 345 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 0 | 109 | Withhold |
| Advisors' Inner Circle Fund III | 55 | 0 | 0 | 0 | For |
| T. Rowe Price | 13 | 0 | 0 | 0 | For |
| Nationwide | 2 | 0 | 0 | 0 | For |
Meeting held March 11, 2025.
Combines 3 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: To elect the following members of Class III of the Company's board of directors: Ralph H. "Randy" Thurman
OUTLOOK THERAPEUTICS INC.’s own tally for this item (“Elect Director: Ralph H. "Randy" Thurman”): 9,939,530 for, 1,000,801 withheld, per its Form 8-K filed March 14, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Stockholders elected each of the following nominees to serve as Class III directors on the Company's Board of Directors (the "Board") until the Company's 2028 Annual Meeting of Stockholders or until his successor has been duly elected and qualified.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 22 asset managers below reported 79,401 for, 18,796 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,308 | 0 | 0 | 0 | For |
| BlackRock | 8,773 | 0 | 0 | 0 | For |
| Pacific Life | 7,242 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 6,724 | Withhold |
| Bridge Builder Trust | 4,414 | 0 | 0 | 0 | For |
| Equitable | 2,752 | 0 | 0 | 886 | Mixed |
| Northern Trust | 0 | 0 | 0 | 2,855 | Withhold |
| Global X | 2,501 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 2,234 | Withhold |
| Charles Schwab | 1,888 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 1,771 | Withhold |
| Fidelity | 1,573 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 1,222 | Withhold |
| ProShares | 0 | 0 | 0 | 1,006 | Withhold |
| SEI | 935 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 607 | Withhold |
| State Street | 0 | 0 | 0 | 576 | Withhold |
| Brinker Capital Destinations Trust | 0 | 0 | 0 | 461 | Withhold |
| PENN SERIES FUNDS INC | 0 | 0 | 0 | 345 | Withhold |
| Guggenheim | 0 | 0 | 0 | 109 | Withhold |
| T. Rowe Price | 13 | 0 | 0 | 0 | For |
| Nationwide | 2 | 0 | 0 | 0 | For |
Meeting held March 11, 2025.
93% Approved · of votes cast
Description as filed by funds: TO APPROVE THE AMENDMENT OF OUTLOOK THERAPEUTICS, INC.'S RESTATED CERTIFICATE OF INCORPORATION, OR THE RESTATED CERTIFICATE, TO INCREASE THE TOTAL NUMBER OF SHARES OF OUR COMMON STOCK AUTHORIZED FOR ISSUANCE FROM 60,000,000 SHARES TO 260,000,000 SHARES.
OUTLOOK THERAPEUTICS INC.’s own tally for this item (“3. The amendment of the Company's Restated Certificate of Incorporation to increase the total number of shares of its common stock authorized for issuance from 60,000,000 to 260,000,000 shares”): 10,116,359 for, 802,107 against — passed, per its Form 8-K filed March 14, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the amendment of the Company's Restated Certificate of Incorporation to increase the total number of shares of its common stock authorized for issuance from 60,000,000 to 260,000,000 shares.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 23 asset managers below reported 90,146 for, 8,106 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,308 | 0 | 0 | 0 | For |
| BlackRock | 8,773 | 0 | 0 | 0 | For |
| Pacific Life | 7,242 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 6,724 | 0 | 0 | Against |
| Bridge Builder Trust | 4,414 | 0 | 0 | 0 | For |
| Equitable | 3,638 | 0 | 0 | 0 | For |
| Northern Trust | 2,855 | 0 | 0 | 0 | For |
| Global X | 2,501 | 0 | 0 | 0 | For |
| DWS | 2,234 | 0 | 0 | 0 | For |
| Charles Schwab | 1,888 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,771 | 0 | 0 | 0 | For |
| Fidelity | 1,573 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,222 | 0 | 0 | 0 | For |
| ProShares | 1,006 | 0 | 0 | 0 | For |
| SEI | 935 | 0 | 0 | 0 | For |
| Calvert | 607 | 0 | 0 | 0 | For |
| State Street | 0 | 576 | 0 | 0 | Against |
| Brinker Capital Destinations Trust | 0 | 461 | 0 | 0 | Against |
| PENN SERIES FUNDS INC | 0 | 345 | 0 | 0 | Against |
| Guggenheim | 109 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 55 | 0 | 0 | 0 | For |
| T. Rowe Price | 13 | 0 | 0 | 0 | For |
| Nationwide | 2 | 0 | 0 | 0 | For |
Meeting held March 11, 2025.
Combines 4 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: To approve the potential issuance in excess of 19.99% of our out-standing common stock upon the conversion of a new convertible note at a conversion price per share that is less than the "minimum price" under Nasdaq Listing Rule 5635, if required pursuant to the terms of the convertible note.
OUTLOOK THERAPEUTICS INC.’s own tally for this item (“2. The potential issuance in excess of 19.99% of the Company's outstanding common stock upon the conversion of the Note at a conversion price per share that is less than the "minimum price" under Nasdaq Listing Rule 5635”): 10,366,884 for, 548,242 against — passed, per its Form 8-K filed March 14, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the potential issuance in excess of 19.99% of the Company's outstanding common stock upon the conversion of the Note at a conversion price per share that is less than the "minimum price" under Nasdaq Listing Rule 5635, if required pursuant to the terms of the Note.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 23 asset managers below reported 90,146 for, 8,106 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,308 | 0 | 0 | 0 | For |
| BlackRock | 8,773 | 0 | 0 | 0 | For |
| Pacific Life | 7,242 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 6,724 | 0 | 0 | Against |
| Bridge Builder Trust | 4,414 | 0 | 0 | 0 | For |
| Equitable | 3,638 | 0 | 0 | 0 | For |
| Northern Trust | 2,855 | 0 | 0 | 0 | For |
| Global X | 2,501 | 0 | 0 | 0 | For |
| DWS | 2,234 | 0 | 0 | 0 | For |
| Charles Schwab | 1,888 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,771 | 0 | 0 | 0 | For |
| Fidelity | 1,573 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,222 | 0 | 0 | 0 | For |
| ProShares | 1,006 | 0 | 0 | 0 | For |
| SEI | 935 | 0 | 0 | 0 | For |
| Calvert | 607 | 0 | 0 | 0 | For |
| State Street | 0 | 576 | 0 | 0 | Against |
| Brinker Capital Destinations Trust | 0 | 461 | 0 | 0 | Against |
| PENN SERIES FUNDS INC | 0 | 345 | 0 | 0 | Against |
| Guggenheim | 109 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 55 | 0 | 0 | 0 | For |
| T. Rowe Price | 13 | 0 | 0 | 0 | For |
| Nationwide | 2 | 0 | 0 | 0 | For |
Meeting held August 12, 2024; no official results are on file for this meeting.
98% of fund votes cast · no official result
Description as filed by funds: TO APPROVE THE OUTLOOK THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN.
The 27 asset managers below reported 339,917 for, 7,736 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 197,617 | 0 | 0 | 0 | For |
| BlackRock | 66,989 | 0 | 0 | 0 | For |
| Charles Schwab | 17,730 | 0 | 0 | 0 | For |
| Fidelity | 15,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 12,815 | 0 | 0 | 0 | For |
| Global X | 7,980 | 0 | 0 | 0 | For |
| Lincoln Financial | 6,724 | 0 | 0 | 0 | For |
| Northern Trust | 3,852 | 0 | 0 | 0 | For |
| State Street | 3,033 | 0 | 0 | 0 | For |
| Equitable | 2,269 | 454 | 0 | 0 | Mixed |
| Pacific Life | 2,431 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 1,330 | 0 | 0 | 0 | For |
| DWS | 0 | 1,271 | 0 | 0 | Against |
| John Hancock | 0 | 1,253 | 0 | 0 | Against |
| Voya | 0 | 1,213 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 1,040 | 0 | 0 | Against |
| Victory Capital | 0 | 958 | 0 | 0 | Against |
| SEI | 935 | 0 | 0 | 0 | For |
| ProShares | 0 | 793 | 0 | 0 | Against |
| Calvert | 0 | 607 | 0 | 0 | Against |
| Brinker Capital Destinations Trust | 461 | 0 | 0 | 0 | For |
| Morgan Stanley | 347 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 345 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 108 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 59 | 0 | 0 | 0 | For |
Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).
Meeting held March 11, 2025.
Combines 3 wordings of this item as funds reported it.
92% Approved · of votes cast
Description as filed by funds: A NON-BINDING ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
OUTLOOK THERAPEUTICS INC.’s own tally for this item (“5. A non-binding advisory vote on the compensation of the Company's named executive officers”): 9,972,197 for, 908,929 against — passed, per its Form 8-K filed March 14, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved a non-binding advisory vote on the compensation of the Company's named executive officers.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 49,308 | 0 | 0 | Against |
| BlackRock | 8,773 | 0 | 0 | 0 | For |
| Pacific Life | 7,242 | 0 | 0 | 0 | For |
| Lincoln Financial | 6,724 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,414 | 0 | 0 | 0 | For |
| Equitable | 2,752 | 886 | 0 | 0 | Mixed |
| Northern Trust | 2,855 | 0 | 0 | 0 | For |
| Global X | 2,501 | 0 | 0 | 0 | For |
| DWS | 0 | 2,234 | 0 | 0 | Against |
| Charles Schwab | 1,888 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 1,771 | 0 | 0 | Against |
| Fidelity | 1,573 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 1,222 | 0 | 0 | Against |
| ProShares | 0 | 1,006 | 0 | 0 | Against |
| SEI | 935 | 0 | 0 | 0 | For |
| Calvert | 0 | 607 | 0 | 0 | Against |
| State Street | 576 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 461 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 345 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 109 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 0 | 55 | 0 | 0 | Against |
| T. Rowe Price | 0 | 13 | 0 | 0 | Against |
| Nationwide | 2 | 0 | 0 | 0 | For |
Fund voting reports, all 23 managers: 41,041 for, 57,211 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 193,152 | 0 | 0 | 0 | For |
| State Street | 152,253 | 609 | 0 | 0 | For |
| BlackRock | 107,698 | 0 | 0 | 0 | For |
| Point72 | 0 | 95,574 | 0 | 0 | Against |
| SCOTIA CAPITAL INC. | 0 | 73,989 | 0 | 0 | Against |
| Northern Trust | 43,550 | 495 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 20,522 | 0 | 0 | 0 | For |
| DWS | 0 | 12,269 | 0 | 0 | Against |
| Vanguard | 0 | 11,425 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 10,391 | 0 | 0 | Against |
| PNC BANK, NATIONAL ASSOCIATION | 10,080 | 0 | 0 | 0 | For |
| Fifth Third Wealth Advisors LLC | 0 | 10,000 | 0 | 0 | Against |
| FIRST MERCHANTS CORP | 0 | 7,458 | 0 | 0 | Against |
| JPMorgan | 0 | 6,759 | 0 | 0 | Against |
| Woodline Partners LP | 5,425 | 0 | 0 | 0 | For |
| Corient Private Wealth LLC | 5,100 | 0 | 0 | 0 | For |
| Citibank, N.A. | 0 | 4,600 | 0 | 0 | Against |
| CAPTRUST FINANCIAL ADVISORS | 0 | 3,806 | 0 | 0 | Against |
| Rhumbline | 0 | 3,638 | 0 | 0 | Against |
| Citadel | 3,213 | 0 | 0 | 0 | For |
| Ethic Inc. | 0 | 3,103 | 0 | 0 | Against |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 2,750 | 0 | 0 | 0 | For |
| SCS Capital Management LLC | 2,500 | 0 | 0 | 0 | For |
| BNY Mellon | 2,440 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 2,405 | 0 | 0 | 0 | For |
Institutional-manager reports, all 67 managers: 562,953 for, 255,377 against. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held March 11, 2025.
98% Approved · of votes cast
Description as filed by funds: TO RATIFY THE SELECTION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL 2025.
OUTLOOK THERAPEUTICS INC.’s own tally for this item (“4. The selection by the Audit Committee of the Board of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year ending September 30, 2025”): 15,943,368 for, 251,344 against — passed, per its Form 8-K filed March 14, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the selection by the Audit Committee of the Board of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year ending September 30, 2025.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 23 asset managers below reported 98,252 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 49,308 | 0 | 0 | 0 | For |
| BlackRock | 8,773 | 0 | 0 | 0 | For |
| Pacific Life | 7,242 | 0 | 0 | 0 | For |
| Lincoln Financial | 6,724 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,414 | 0 | 0 | 0 | For |
| Equitable | 3,638 | 0 | 0 | 0 | For |
| Northern Trust | 2,855 | 0 | 0 | 0 | For |
| Global X | 2,501 | 0 | 0 | 0 | For |
| DWS | 2,234 | 0 | 0 | 0 | For |
| Charles Schwab | 1,888 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,771 | 0 | 0 | 0 | For |
| Fidelity | 1,573 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,222 | 0 | 0 | 0 | For |
| ProShares | 1,006 | 0 | 0 | 0 | For |
| SEI | 935 | 0 | 0 | 0 | For |
| Calvert | 607 | 0 | 0 | 0 | For |
| State Street | 576 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 461 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 345 | 0 | 0 | 0 | For |
| Guggenheim | 109 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 55 | 0 | 0 | 0 | For |
| T. Rowe Price | 13 | 0 | 0 | 0 | For |
| Nationwide | 2 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 32,017,179 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 0.62% |
| 2 | BlackRock | 0.21% |
| 3 | Charles Schwab | 0.06% |
| 4 | Fidelity | 0.05% |
| 5 | QUANTITATIVE MASTER SERIES LLC | 0.04% |
| 6 | Global X | 0.02% |
| 7 | Lincoln Financial | 0.02% |
| 8 | Northern Trust | 0.01% |
| 9 | State Street | <0.01% |
| 10 | Equitable | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 0.60% |
| 2 | State Street | 0.48% |
| 3 | BlackRock | 0.34% |
| 4 | Point72 | 0.30% |
| 5 | SCOTIA CAPITAL INC. | 0.23% |
| 6 | Northern Trust | 0.14% |
| 7 | MELLON INVESTMENTS Corp | 0.06% |
| 8 | DWS | 0.04% |
| 9 | Vanguard | 0.04% |
| 10 | PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0.03% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| GMS Ventures and Investments | — | DEF14A |
| Intracoastal Capital LLC | — | 13G |
| Sphera Funds Management Ltd. | — | 13G |
| Syntone Ventures, LLC | — | DEF14A |
| Entities affiliated with Great Point Partners LLC | — | DEF14A |
| Empery Asset Management, LP | — | 13G |
| Great Point Partners, LLC | — | 13G |
| Tang Capital Partners, LP | — | DEF14A |
| TANG CAPITAL MANAGEMENT, LLC | — | 13G |
| Entities affiliated with Sphera | — | DEF14A |
Percentages above are of 32,017,179 shares outstanding, as reported by OUTLOOK THERAPEUTICS INC. on its Form 10-Q dated February 12, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from OUTLOOK THERAPEUTICS INC.’s 10-Q dated February 12, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
OUTLOOK THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page).
proxyvotesnow.com, “OUTLOOK THERAPEUTICS (OTLK) 2024-2025 Shareholder Meetings”, https://proxyvotesnow.com/company/outlook-therapeutics-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.